KR101852502B1 - 조성물에 관한 개선 - Google Patents

조성물에 관한 개선 Download PDF

Info

Publication number
KR101852502B1
KR101852502B1 KR1020137022830A KR20137022830A KR101852502B1 KR 101852502 B1 KR101852502 B1 KR 101852502B1 KR 1020137022830 A KR1020137022830 A KR 1020137022830A KR 20137022830 A KR20137022830 A KR 20137022830A KR 101852502 B1 KR101852502 B1 KR 101852502B1
Authority
KR
South Korea
Prior art keywords
aqueous solution
per liter
present
solution
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137022830A
Other languages
English (en)
Korean (ko)
Other versions
KR20140007881A (ko
Inventor
크리스 셀돈
던 패드필드
프란시스 모리세이
Original Assignee
노어긴 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1101666.4A external-priority patent/GB201101666D0/en
Priority claimed from GBGB1101738.1A external-priority patent/GB201101738D0/en
Priority claimed from GBGB1200637.5A external-priority patent/GB201200637D0/en
Application filed by 노어긴 비.브이. filed Critical 노어긴 비.브이.
Publication of KR20140007881A publication Critical patent/KR20140007881A/ko
Application granted granted Critical
Publication of KR101852502B1 publication Critical patent/KR101852502B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
KR1020137022830A 2011-01-31 2012-01-31 조성물에 관한 개선 Active KR101852502B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1101666.4A GB201101666D0 (en) 2011-01-31 2011-01-31 Improvements in and relating to compositions
GB1101666.4 2011-01-31
GBGB1101738.1A GB201101738D0 (en) 2011-02-01 2011-02-01 Improvements in and relating to compositions
GB1101738.1 2011-02-01
GBGB1200637.5A GB201200637D0 (en) 2012-01-13 2012-01-13 Improvements in and relating to compositions
GB1200637.5 2012-01-13
PCT/GB2012/050195 WO2012104617A1 (en) 2011-01-31 2012-01-31 Improvements in and relating to compositions

Publications (2)

Publication Number Publication Date
KR20140007881A KR20140007881A (ko) 2014-01-20
KR101852502B1 true KR101852502B1 (ko) 2018-04-26

Family

ID=45563438

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137022830A Active KR101852502B1 (ko) 2011-01-31 2012-01-31 조성물에 관한 개선

Country Status (17)

Country Link
EP (2) EP2670391A1 (enExample)
JP (2) JP2014504628A (enExample)
KR (1) KR101852502B1 (enExample)
CN (2) CN107260661A (enExample)
AU (1) AU2012213180B2 (enExample)
BR (1) BR112013019418B1 (enExample)
CY (1) CY1125270T1 (enExample)
DE (1) DE202012013349U1 (enExample)
DK (1) DK2862566T3 (enExample)
EA (1) EA028925B1 (enExample)
ES (1) ES2914034T3 (enExample)
HR (1) HRP20220691T1 (enExample)
MX (1) MX360450B (enExample)
PL (1) PL2862566T3 (enExample)
PT (1) PT2862566T (enExample)
WO (1) WO2012104617A1 (enExample)
ZA (1) ZA201305342B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
NZ743984A (en) 2012-09-11 2019-10-25 Norgine Bv Compositions comprising polyethylene glycol, alkali metal or alkaline earth metal sulphates and electrolytes for use as colon cleansing compositions
JP6441890B2 (ja) 2013-03-15 2018-12-19 ブレインツリー・ラボラトリーズ,インコーポレイテッド 硫酸塩の両用経口薬学的組成物錠剤およびその使用の方法
WO2016208781A1 (ko) * 2015-06-22 2016-12-29 주식회사 씨티씨바이오 장관 세척용 하제 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE477790T1 (de) * 2001-10-29 2010-09-15 Ajinomoto Kk Lösung zur darmreinigung
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
WO2006122104A1 (en) * 2005-05-06 2006-11-16 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
GB0912487D0 (en) * 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049049A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate

Also Published As

Publication number Publication date
MX2013008635A (es) 2013-11-04
PT2862566T (pt) 2022-06-02
DE202012013349U1 (de) 2016-06-27
ES2914034T3 (es) 2022-06-07
AU2012213180B2 (en) 2017-04-13
EP2862566A1 (en) 2015-04-22
CN103458874A (zh) 2013-12-18
EP2670391A1 (en) 2013-12-11
BR112013019418B1 (pt) 2022-03-29
KR20140007881A (ko) 2014-01-20
HRP20220691T1 (hr) 2022-07-08
PL2862566T3 (pl) 2022-06-20
EA028925B1 (ru) 2018-01-31
JP2018035181A (ja) 2018-03-08
JP2014504628A (ja) 2014-02-24
DK2862566T3 (da) 2022-05-16
CY1125270T1 (el) 2024-12-13
WO2012104617A1 (en) 2012-08-09
BR112013019418A2 (enExample) 2017-08-29
MX360450B (es) 2018-11-01
JP6498250B2 (ja) 2019-04-10
CN107260661A (zh) 2017-10-20
NZ613401A (en) 2016-03-31
EP2862566B1 (en) 2022-03-09
ZA201305342B (en) 2014-12-23
EA201300882A1 (ru) 2014-01-30

Similar Documents

Publication Publication Date Title
US9468686B2 (en) Solutions comprising polyethylene glycol and electrolytes
KR101852502B1 (ko) 조성물에 관한 개선
AU2012213180A1 (en) Improvements in and relating to compositions
NZ613401B2 (en) Polyethylene Glycol Solutions for Use in the Treatment of Constipation
JP4304029B2 (ja) シロスタゾールゼリー状医薬組成物
DE202010016398U1 (de) Verbesserungen bei pharmazeutischen Zusammensetzungen und bezüglich pharmazeutischer Zusammensetzungen
DE202012001673U1 (de) Lösungen zur Behandlung von Obstipation und/oder Impaktbildung

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20130828

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20170131

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20171114

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20180330

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20180420

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20180423

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20210326

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20220324

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20230328

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20240325

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20250325

Start annual number: 8

End annual number: 8